Long COVID Genetic Testing: What Consumer DNA Can and Cannot Show

What Long COVID Genetic Testing Can and Cannot Tell You

If you live with lingering symptoms after a SARS-CoV-2 infection, you may wonder whether long COVID genetic testing could explain why your recovery looks so different from other people's. It is a reasonable question. Research suggests that genetic factors may influence who develops Long COVID, how severe symptoms become, and how long they last.

There is one thing to say clearly first: no genetic test can confirm or rule out Long COVID. Long COVID is identified through your history, your symptoms and a clinical assessment, not through a DNA sample. Consumer DNA services such as 23andMe or AncestryDNA were not designed for this purpose, and a variant in your results does not mean you have, or will develop, any condition.

What these tests can do is more modest. They read hundreds of thousands of specific positions in your genome. Some of those positions sit in genes that researchers are studying in relation to how the body handles SARS-CoV-2. Exploring them can give you informational context about biological pathways. It cannot give you answers about your health on its own.

How the Mechanism Works: Viral Entry and Antiviral Defence

To see why certain genes attract research interest, it helps to look at two broad stages of infection.

Getting into cells. SARS-CoV-2 has to attach to and enter human cells. This process depends on receptors on the cell surface and on enzymes that "prime" or cut the virus's spike protein so it can fuse with the cell. Studies have explored whether natural genetic variation in these host proteins affects how efficiently the virus enters. This area is often described as viral entry and host susceptibility.

Fighting the virus once it is inside. The body's antiviral response involves detecting the virus, producing signalling molecules called interferons, and clearing infected material from cells. If this response is slower or less effective, one research hypothesis is that viral components could linger. Another is that inflammation could become dysregulated. Both ideas are being investigated as possible contributors to persistent symptoms.

Genes involved in either stage are natural candidates for study. Still, Long COVID is complex, and no single gene is thought to explain it.

Relevant Genes and Variants

Below are genes in the ChronicDNA dataset that research has linked to these pathways. The evidence is emerging, and findings for individual variants should be read with caution.

Viral entry genes

• ACE2 encodes the primary entry receptor for SARS-CoV-2. It also helps regulate the renin-angiotensin system in the heart, blood vessels and lungs. Research suggests that ACE2 downregulation after infection may contribute to excess angiotensin II, vascular dysfunction and lung injury in Long COVID. Variants studied include rs2285666 and rs4240157.
• TMPRSS2 encodes a serine protease that primes the spike protein so the virus can enter cells. Variants affecting entry efficiency may influence initial viral load and later immune dysregulation. Variants of interest include rs12329760 and rs2070788.
• FURIN encodes an enzyme that cleaves the spike protein at the S1/S2 site, which is a distinctive feature of SARS-CoV-2. This cleavage is considered important for efficient entry and cell-to-cell fusion. Studies have explored variants such as rs17514846 and rs2521501.
• BSG encodes CD147, also called basigin. CD147 has been proposed as a co-receptor for the spike protein through the cyclophilin pathway, and it may also be involved in inflammatory signalling. One variant of interest is rs8259.
• PPIA encodes cyclophilin A. During inflammation, cyclophilin A can be secreted and bind CD147. Variants such as rs6850 may affect CD147-dependent entry and inflammatory cascades.

Antiviral defence genes

• IFNL1 encodes interferon lambda-1, a type III interferon that acts mainly at mucosal surfaces such as the airways. Research suggests these responses may influence early clearance of the virus. A variant studied is rs8103142.
• IFNL3 encodes interferon lambda-3. Its variant rs12979860 is described as the most replicated pharmacogenetic variant predicting interferon responses, and rs8099917 is also of interest. Variation here may influence Long COVID severity and recovery.
• IRGM encodes a protein that promotes xenophagy, which is the autophagic clearance of pathogens inside cells. Variants affecting IRGM expression, such as rs13361189 and rs4958847, have been proposed as possible contributors to viral persistence.

Practical Implications of Your Results

If you look at your genetic data with Long COVID in mind, a few honest principles can help keep expectations grounded.

Consumer tests are not complete. Genotyping chips read selected positions, not your whole genome. Some variants listed above may not appear in your file at all, and coverage differs between companies and chip versions. A missing variant is not a negative result. It simply was not measured.

Associations are not predictions. When research links a variant to an outcome, it usually describes a small shift in probability across large groups of people. It does not tell you what happened, or will happen, in your own body.

Results cannot guide medical decisions alone. Information about these pathways cannot tell you which approach will help your symptoms. Please do not change medications or start new products based on raw DNA data. A doctor or genetic counsellor can help you put any findings in context alongside your full clinical picture.

Context can still be valuable. Many people with Long COVID find it meaningful to understand the biology being researched. It can support more informed conversations with healthcare professionals and help make sense of an illness that is often poorly understood.

How to Explore Your Raw DNA Data

If you have already tested with a consumer service, you can usually download your raw data from your account settings. The file is typically a plain text list. Each line shows a variant identifier (an "rs number"), its chromosome, its position and your genotype, written as two letters such as AG or CC.

To explore it:

1. Download the file from your provider and store it carefully, since it is sensitive personal information.
2. Search for specific rs numbers, such as rs12979860 or rs2285666, using a text editor's search function.
3. Check whether a result is present. Some lines may show dashes or blanks. These are "no-calls," meaning the chip could not read that position reliably.
4. Be cautious with interpretation. Different companies sometimes report the DNA strand differently, so the same genotype can appear as different letters. Comparing letters to published research without accounting for this can be misleading.

This is where a structured report can help. It matches your file against curated variant information and explains each finding in plain language, without overstating what it means.

Get Personalized DNA Insights

If you already have raw data from 23andMe, AncestryDNA or a similar service, ChronicDNA can organise it into an informational report. The report covers genes linked to viral entry, interferon signalling and other pathways being studied in Long COVID and ME/CFS. It is designed to support understanding and better conversations with your healthcare team, not to replace them. Get your ChronicDNA report